Regulatory Networks and Complex Interactions Between the Insulin and Angiotensin II Signalling Systems: Models and Implications for Hypertension and Diabetes

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Jan 9

PMID 24400038

Citations 6

Authors

Deniz Cizmeci

Yaman Arkun

Affiliations

Soon will be listed here.

Abstract

The cross-talk between insulin and angiotensin II signalling pathways plays a significant role in the co-occurrence of diabetes and hypertension. We developed a mathematical model of the system of interactions among the biomolecules that are involved in the cross-talk between the insulin and angiotensin II signalling pathways. We have identified several feedback structures that regulate the dynamic behavior of the individual signalling pathways and their interactions. Different scenarios are simulated and dominant steady-state, dynamic and stability characteristics are revealed. The proposed mechanistic model describes how angiotensin II inhibits the actions of insulin and impairs the insulin-mediated vasodilation. The model also predicts that poor glycaemic control induced by diabetes contributes to hypertension by activating the renin angiotensin aystem.

Citing Articles

Detection of biological switches using the method of Gröebner bases.

Arkun Y BMC Bioinformatics. 2019; 20(1):615.

PMID: 31779580 PMC: 6883700. DOI: 10.1186/s12859-019-3155-0.

Subcutaneous adipose tissue imaging of human obesity reveals two types of adipocyte membranes: Insulin-responsive and -nonresponsive.

McCormick C, Waters H, Bezrukov L, Taginya R, Parikh V, Onyekaba G J Biol Chem. 2018; 293(37):14249-14259.

PMID: 30006347 PMC: 6139566. DOI: 10.1074/jbc.RA118.003751.

Dynamic Modeling and Analysis of the Cross-Talk between Insulin/AKT and MAPK/ERK Signaling Pathways.

Arkun Y PLoS One. 2016; 11(3):e0149684.

PMID: 26930065 PMC: 4773096. DOI: 10.1371/journal.pone.0149684.

Reactive Oxygen Species in the Paraventricular Nucleus of the Hypothalamus Alter Sympathetic Activity During Metabolic Syndrome.

Cruz J, Flor A, Franca-Silva M, Balarini C, Braga V Front Physiol. 2016; 6:384.

PMID: 26779026 PMC: 4688401. DOI: 10.3389/fphys.2015.00384.

Human adipose cells in vitro are either refractory or responsive to insulin, reflecting host metabolic state.

Lizunov V, Stenkula K, Blank P, Troy A, Lee J, Skarulis M PLoS One. 2015; 10(3):e0119291.

PMID: 25768970 PMC: 4359092. DOI: 10.1371/journal.pone.0119291.

References

Manning B . Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol. 2004; 167(3):399-403. PMC: 2172491. DOI: 10.1083/jcb.200408161. View

Saltiel A, Kahn C . Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001; 414(6865):799-806. DOI: 10.1038/414799a. View

Andreozzi F, Laratta E, Sciacqua A, Perticone F, Sesti G . Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Circ Res. 2004; 94(9):1211-8. DOI: 10.1161/01.RES.0000126501.34994.96. View

Henriksen E, Jacob S, Kinnick T, Teachey M, Krekler M . Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension. 2001; 38(4):884-90. DOI: 10.1161/hy1101.092970. View

Paz K, Liu Y, Shorer H, Hemi R, LeRoith D, Quan M . Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function. J Biol Chem. 1999; 274(40):28816-22. DOI: 10.1074/jbc.274.40.28816. View

Hara K, Yonezawa K, Weng Q, Kozlowski M, Belham C, Avruch J . Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem. 1998; 273(23):14484-94. DOI: 10.1074/jbc.273.23.14484. View

OReilly K, Rojo F, She Q, Solit D, Mills G, Smith D . mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res. 2006; 66(3):1500-8. PMC: 3193604. DOI: 10.1158/0008-5472.CAN-05-2925. View

Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy A . Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 1999; 283(5407):1544-8. DOI: 10.1126/science.283.5407.1544. View

Peti-Peterdi J, Kang J, Toma I . Activation of the renal renin-angiotensin system in diabetes--new concepts. Nephrol Dial Transplant. 2008; 23(10):3047-9. PMC: 2720812. DOI: 10.1093/ndt/gfn377. View

10.

Nawano M, Anai M, Funaki M, Kobayashi H, Kanda A, Fukushima Y . Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat. Metabolism. 1999; 48(10):1248-55. DOI: 10.1016/s0026-0495(99)90263-9. View

11.

Henriksen E . Improvement of insulin sensitivity by antagonism of the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2007; 293(3):R974-80. DOI: 10.1152/ajpregu.00147.2007. View

12.

Cong L, Chen H, Li Y, Zhou L, McGibbon M, Taylor S . Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol Endocrinol. 1998; 11(13):1881-90. DOI: 10.1210/mend.11.13.0027. View

13.

Raught B, Gingras A, Sonenberg N . The target of rapamycin (TOR) proteins. Proc Natl Acad Sci U S A. 2001; 98(13):7037-44. PMC: 34619. DOI: 10.1073/pnas.121145898. View

14.

Guo W, Adachi T, Matsui R, Xu S, Jiang B, Zou M . Quantitative assessment of tyrosine nitration of manganese superoxide dismutase in angiotensin II-infused rat kidney. Am J Physiol Heart Circ Physiol. 2003; 285(4):H1396-403. DOI: 10.1152/ajpheart.00096.2003. View

15.

Kurtz A, Wagner C . Role of nitric oxide in the control of renin secretion. Am J Physiol. 1998; 275(6):F849-62. DOI: 10.1152/ajprenal.1998.275.6.F849. View

16.

Thomas G, Hall M . TOR signalling and control of cell growth. Curr Opin Cell Biol. 1998; 9(6):782-7. DOI: 10.1016/s0955-0674(97)80078-6. View

17.

Kobori H, Nangaku M, Navar L, Nishiyama A . The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007; 59(3):251-87. DOI: 10.1124/pr.59.3.3. View

18.

Tee A, Blenis J . mTOR, translational control and human disease. Semin Cell Dev Biol. 2005; 16(1):29-37. DOI: 10.1016/j.semcdb.2004.11.005. View

19.

Liao Y, Hung M . Physiological regulation of Akt activity and stability. Am J Transl Res. 2010; 2(1):19-42. PMC: 2826820. View

20.

Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A . Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest. 2008; 118(9):3065-74. PMC: 2518073. DOI: 10.1172/JCI34739. View